Sign in

CIK 0001022079

  • Large accelerated filer

QUEST DIAGNOSTICS INC

Sign in to watch
Ticker
DGX
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
161387862
Phone
+1 973-520-2700
Business address
500 PLAZA DRIVE, SECAUCUS, NJ, 07094
Former names
CORNING CLINICAL LABORATORIES INC
  1. 4 Other acquisition Executive Vice President & CFO acquired 74 shares (code L)
  2. 4 Other acquisition SVP, Clinical Solutions acquired 27 shares (code L)
  3. 4 Other acquisition SVP for Diagnostic Services acquired 81 shares (code L)
  4. 4 Grant or award Director acquired 68 shares (grant or award)
  5. 4 Other acquisition SVP & Chief Commercial Officer acquired 25 shares (code L)
  6. 4 Planned sale CEO and President sold 39,191 shares at an average $168.46 ($6,602,074)
  7. 4 Planned sale SVP, Clinical Solutions sold 2,555 shares at $170.00 ($434,350)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Shares withheld for taxes SVP for Diagnostic Services gave up 162 shares (to pay taxes)
  11. 4 Shares withheld for taxes SVP & Chief Commercial Officer gave up 256 shares (to pay taxes)
  12. 4 Planned sale SVP & General Counsel sold 4,643 shares at $170.00 ($789,310)
  13. 4 Planned sale EVP, Regional Businesses sold 5,370 shares at $174.13 ($935,078)
  14. 4 Shares withheld for taxes SVP, Corp. Controller & CAO gave up 2,559 shares (to pay taxes)
  15. 4 Planned sale EVP, Regional Businesses sold 716 shares at $175.79 ($125,866)
  16. 4 Grant or award CEO and President acquired 61,917 shares (grant or award)
  17. 4 Grant or award SVP, Clinical Solutions acquired 4,434 shares (grant or award)
  18. 4 Grant or award SVP for Diagnostic Services acquired 5,674 shares (grant or award)
  19. 4 Planned sale SVP & General Counsel sold 592 shares at $175.79 ($104,068)
  20. 4 Grant or award SVP & Chief Commercial Officer acquired 5,317 shares (grant or award)

Page 7 of 74 · 1,466 filings